Search Results

Generative AI pilots are now common in biopharma, but scaling these innovations enterprise-wide is where most teams stall. In this webinar hosted by Patsnap, we’ll share practical examples of how leading biopharma companies are unlocking real value across the R&D and commercialization value chain. You’ll also see how a top R&D spender broke down silos across multidisciplinary teams through the power of data, validated generative AI, and human-in-the-loop approaches that ensure responsible, ethical use.

Sales of Johnson & Johnson’s esketamine-based nasal spray jumped in the fourth quarter last year, priming the pump for a suite of other pharmas, including AbbVie, champing at the bit with their own psychedelics.

With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth.

Key Commercialization Milestone in Retail Pharmacy Network that Serves Over 2.8 Million Insured Members

Live Production Marketplace Now Available

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform.

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.

According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data.